Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from NYSE

Armstrong World Indus's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Armstrong World Indus (NYSE:AWI) earned $44.40 million, a 5.97% increase from the preceding quarter. Armstrong World Indus also posted a total of $282.60 million in sales, a 0.04% increase since Q4.

Benzinga

Waste Management Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Waste Management (NYSE:WM) earned $514.00 million, a 1.58% increase from the preceding quarter. Waste Management's sales decreased to $4.66 billion, a 0.36% change since Q4.

Benzinga

Archer-Daniels Midland's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Archer-Daniels Midland (NYSE:ADM) earned $1.06 billion, a 33.5% increase from the preceding quarter. Archer-Daniels Midland also posted a total of $23.65 billion in sales, a 2.43% increase since Q4.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Raytheon Technologies's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Raytheon Technologies (NYSE:RTX) posted Q1 earnings of $1.11 billion, an increase from Q4 of 43.39%. Sales dropped to $15.72 billion, a 7.79% decrease between quarters.

Benzinga

Arch Coal's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Arch Coal (NYSE:ARCH) earned $271.87 million, a 19.98% increase from the preceding quarter. Arch Coal also posted a total of $867.94 million in sales, a 7.72% increase since Q4.

Benzinga

General Electric Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, General Electric's (NYSE:GE) reported sales totaled $17.04 billion. Despite a 73.58% increase in earnings, the company posted a loss of $1.01 billion.

Benzinga

Pfizer Injects $25M Via Equity In Zentalis Pharma

Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) will sell 953,834 common shares at $26.21 per share to Pfizer Inc (NYSE:PFE) for $25 million. The offering is expected to close by April 29. Zentalis will use the proceeds to fund ongoing and planned clinical trials, including studies of ZN-c3 and ZN-d5, and for working capital and general corporate…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into General Motors's Return On Capital Employed

According to Benzinga Pro, during Q1, General Motors (NYSE:GM) earned $2.81 billion, a 58.95% increase from the preceding quarter. General Motors also posted a total of $35.98 billion in sales, a 7.13% increase since Q4.

Benzinga

Why Visa Shares Are Trading Higher Today

Visa Inc (NYSE: V) shares are trading higher Wednesday after the company reported better-than-expected financial results.

Benzinga

Stock Wars: Darden Restaurants Vs. Dave & Buster's

Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment.

Benzinga

Mid-Morning Market Update: Markets Open Higher; Dow Gains 300 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022

Benzinga

Cathie Wood-Backed EV Maker Xpeng Clinches $1.14B Term Loan Deal To Fund Growth

Chinese electric vehicle maker XPeng, Inc. (NYSE: XPEV) has signed an agreement that would secure additional funding for the company to fuel growth.

Benzinga

Dana Q1 Earnings Tops Estimates; Cuts FY22 EPS Outlook

Dana Inc (NYSE:DAN) reported first-quarter FY22 sales growth of 9.6% year-on-year to $2.48 billion, beating the consensus of $2.24 billion. Light vehicle revenue fell 0.6% Y/Y, Commercial vehicles increased 32.7%, Off-Highway climbed 17.2%, and Power Technologies sales were flat. Adjusted EBITDA was $170 million versus $234 million last year. Selling, general and administrative…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Boston Scientific Jumps On Upbeat Q2, FY22 Guidance

Boston Scientific Corp (NYSE:BSX) generated net sales of $3.026 billion in Q1 FY22, beating the Wall Street estimate of $2.95 billion. Sales increased 10% Y/Y on a reported basis, 12.6% on an operational basis, and 9.7% on an organic basis, better than the management estimate of approximately 5% - 8%. The Company achieved…

Benzinga

Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio

Acutus Medical Inc (NASDAQ:AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has also agreed to sell its left-heart access portfolio to Medtronic plc (NYSE:MDT). The combination of these two transactions, taken together with the Company’s recently completed restructuring,…

Benzinga

Recap: Gorman-Rupp Q1 Earnings

Gorman-Rupp (NYSE:GRC) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Where Universal Health Services Stands With Analysts

Analysts have provided the following ratings for Universal Health Services (NYSE:UHS) within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Where Capital One Financial Stands With Analysts

Within the last quarter, Capital One Financial (NYSE:COF) has observed the following analyst ratings:

Benzinga

Analyst Ratings for Roblox

Within the last quarter, Roblox (NYSE:RBLX) has observed the following analyst ratings:

Benzinga

What 5 Analyst Ratings Have To Say About Rush Street Interactive

Rush Street Interactive (NYSE:RSI) has observed the following analyst ratings within the last quarter:

Benzinga

Analyst Ratings for Ecolab

Ecolab (NYSE:ECL) has observed the following analyst ratings within the last quarter:

Benzinga

Where Carter's Stands With Analysts

Analysts have provided the following ratings for Carter's (NYSE:CRI) within the last quarter:

Benzinga

Expert Ratings for OGE Energy

Over the past 3 months, 4 analysts have published their opinion on OGE Energy (NYSE:OGE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Expert Ratings for Medical Properties Trust

Within the last quarter, Medical Properties Trust (NYSE:MPW) has observed the following analyst ratings:

1 … 344 345 346 347

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.